HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trudy M Forte Selected Research

Apolipoproteins A

3/2016Apolipoprotein A-V gene therapy for disease prevention / treatment: a critical analysis.
4/2013Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol.
3/2013Gene transfer of apolipoprotein A-V improves the hypertriglyceridemic phenotype of apoa5 (-/-) mice.
5/2012Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement.
12/2010Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.
5/2010Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation.
11/2009Apolipoprotein A-V N-terminal domain lipid interaction properties in vitro explain the hypertriglyceridemic phenotype associated with natural truncation mutants.
4/2009The ins (cell) and outs (plasma) of apolipoprotein A-V.
8/2008Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Trudy M Forte Research Topics

Disease

5Hypertriglyceridemia
03/2016 - 11/2009
4Atherosclerosis
04/2013 - 01/2002
4Neoplasms (Cancer)
08/2011 - 01/2005
3Heart Diseases (Heart Disease)
03/2016 - 05/2012
3Hepatocellular Carcinoma (Hepatoma)
05/2010 - 08/2008
2Barth Syndrome
01/2018 - 08/2015
2Lymphoma (Lymphomas)
08/2015 - 08/2011
2Non-alcoholic Fatty Liver Disease
06/2015 - 01/2015
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2011 - 07/2010
2Glioblastoma (Glioblastoma Multiforme)
12/2007 - 01/2007
1Cardiovascular Diseases (Cardiovascular Disease)
03/2016
1Mitochondrial Diseases (Mitochondrial Disease)
08/2015
1Inborn Genetic Diseases (Disease, Hereditary)
08/2015
1Invasive Fungal Infections
01/2013
1Candidiasis (Moniliasis)
01/2013
1Fungal Lung Diseases
10/2010
1Vascular Diseases (Vascular Disease)
12/2005

Drug/Important Bio-Agent (IBA)

9Apolipoproteins AIBA
03/2016 - 08/2008
4Phospholipids (Phosphatides)FDA LinkGeneric
08/2015 - 01/2002
4Triglycerides (Triacylglycerol)IBA
06/2015 - 05/2012
3Apolipoprotein A-VIBA
06/2015 - 08/2008
3HDL LipoproteinsIBA
12/2010 - 01/2002
3LDL Receptors (LDL Receptor)IBA
12/2007 - 03/2002
2Cardiolipins (Cardiolipin)IBA
01/2018 - 08/2015
2LipidsIBA
01/2018 - 11/2009
2Apolipoprotein A-I (Apolipoprotein A1)IBA
08/2015 - 12/2005
2Apolipoproteins E (ApoE)IBA
04/2013 - 03/2002
2Biological ProductsIBA
05/2012 - 08/2011
2Lipoproteins (Lipoprotein)IBA
11/2009 - 08/2008
2Oleic Acid (Oleate)IBA
08/2008 - 12/2007
2Pharmaceutical PreparationsIBA
12/2007 - 01/2007
2LDL Lipoproteins (beta Lipoproteins)IBA
12/2007 - 01/2007
2oxidized low density lipoproteinIBA
12/2007 - 01/2007
2Aryldialkylphosphatase (Paraoxonase)IBA
03/2002 - 01/2002
2EnzymesIBA
03/2002 - 01/2002
1Immunoglobulin FragmentsIBA
08/2015
1Messenger RNA (mRNA)IBA
06/2015
1DisulfidesIBA
10/2014
1liposomal amphotericin BFDA Link
01/2013
1Cyclin D1IBA
08/2011
1CurcuminIBA
08/2011
1high density lipoprotein binding proteinIBA
12/2010
1Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
12/2010
1Amphotericin B (Amphotericin)FDA LinkGeneric
10/2010
1Antifungal AgentsIBA
10/2010
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
07/2010
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2010
1Conditioned Culture MediaIBA
08/2008
1Protein Sorting Signals (Signal Peptide)IBA
08/2008
1Green Fluorescent ProteinsIBA
08/2008
1Proteins (Proteins, Gene)FDA Link
08/2008
1Paclitaxel (Taxol)FDA LinkGeneric
12/2007
1HDL CholesterolIBA
12/2005
1Apolipoproteins B (ApoB)IBA
12/2005
1apolipoprotein A-I MilanoIBA
12/2005
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2005
1Platelet Activating FactorIBA
03/2002
1ApolipoproteinsIBA
03/2002
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
03/2002

Therapy/Procedure

6Therapeutics
01/2018 - 01/2005
1Intravenous Injections
12/2010
1Drug Therapy (Chemotherapy)
07/2010